The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez, F. J.
Right arrow Articles by Deepe, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez, F. J.
Right arrow Articles by Deepe, G. S., Jr.
The Journal of Immunology, 2001, 166: 2855-2862.
Copyright © 2001 by The American Association of Immunologists

V{beta}6+ and V{beta}4+ T Cells Exert Cooperative Activity in Clearance of Secondary Infection with Histoplasma capsulatum1

Francisco J. Gomez*, Erin O. Woodward{dagger}, Robyn Pilcher-Roberts{dagger}, Reta S. Gibbons{dagger} and George S. Deepe, Jr.2,{dagger}

* Research Division, Veterans Administration Medical Center, Cincinnati, OH 45202; {dagger} Division of Infectious Diseases, University of Cincinnati School of Medicine, Cincinnati, OH 45267


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We previously studied the lung V{beta} TCR repertoire of C57BL/6 mice during primary infection with the pathogen Histoplasma capsulatum. We observed a consistent oligoclonal expansion of V{beta}4+ T cells during the peak of infection and early stages of resolution. The V{beta}4+ family played a role in protective immunity against the fungus. Depletion of this subpopulation of T cells hindered optimal clearance of infection from tissues. In this report we analyze the flux of the V{beta} TCR repertoire in the lungs of C57BL/6 mice with reinfection histoplasmosis. We observed a significant increase in V{beta}6+ T cells on days 7, 10, and 14, the peak and early resolution phases of infection. This skewing was preceded by an increased number of memory T cells within V{beta}6+ cells. The VDJ sequences of V{beta}6 chains were oligoclonal during the early stages of the infection, suggesting that the expansion was driven by a small number of Ags. More than 96% of the expanded V{beta}6+ cells were CD4+. Depletion of V{beta}6+ T cells but not V{beta}4+ T cells induced a modest but significant delay in fungal clearance. Simultaneous depletion of V{beta}4+ and V{beta}6+ T cells induced a more pronounced impairment of host resistance. These studies illustrate the dynamic interactions between V{beta} families in the response to microbial challenge.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Histoplasmosis is the clinical manifestation of infection with the dimorphic fungus Histoplasma capsulatum (Hc)3 (1). In the soil, its natural habitat, the organism exists as a saprobic mold. At this stage, the fungus produces microconidia, a specialized structure of asexual propagation that is small enough to become airborne and be inhaled. In the terminal bronchioles and alveoli of the host, microconidia are avidly taken up by macrophages and other professional phagocytes (2, 3). Once in the tissues, the fungus converts to a yeast form that successfully replicates and parasitizes the endosomal compartment of phagocytes. Migration of these cells to local lymph nodes followed by hematogenous circulation to the liver and spleen contributes to the early dissemination observed in this infection. The mammalian host is able to respond to and eventually control infection with Hc by activation of cell-mediated immunity. T cells play a key role in resistance against Hc (1, 4). It is believed that T cells recognize Hc Ags presented by accessory cells, become activated, and secrete an array of cytokines that in turn enable macrophages to inhibit the intracellular growth of the fungus or kill it (5).

T lymphocytes are heterogeneous and can be subclassified according to the expression of different surface molecules. We have characterized the role of different T cell subpopulations in resistance against the Hc infection (6, 7, 8, 9, 10). Recently, we focused on the most heterogeneous of the T cell surface molecules, the TCR, by using the variable element of the {beta}-chain as a marker to identify T cell V{beta} families involved in resistance against the fungus (11). We previously reported that T cells bearing the V{beta}4+ chain are expanded in the lungs of mice during the peak and early clearance phases of primary infection. This expansion of V{beta}4+ T cells has a functional correlate: deletion of the V{beta}4+ subset of T cells hinders optimal clearance of the fungus from tissues.

Following resolution of primary infection, mice become resistant to a secondary challenge with the fungus. The cellular immune response in reexposure histoplasmosis is qualitatively different from that of primary infection (9, 12). In this study, we analyzed the V{beta} TCR repertoire in the lungs of C57BL/6 mice that had been rechallenged with Hc by the intranasal (i.n.) route. We found expansion of V{beta}6+ T cells on days 7, 10, and 14 of reinfection. Sequence analysis of the complementarity determinant region (CDR)3 revealed oligoclonality during the acute stages after inoculation. Depletion of V{beta}6+ but not V{beta}4+ T cells produced a modest impairment in fungal recovery on day 7 of infection. However, simultaneous depletion of V{beta}6+ and V{beta}4+ T cells resulted in a more profound impairment in host resistance. These results indicate that reexposure histoplasmosis is accompanied by a bias in the TCR repertoire that is distinct from that of primary infection and that V{beta}6+ and V{beta}4+ cells act cooperatively in host resistance to reinfection.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

Five-week-old male C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Athymic nude mice, 6 wk of age, were purchased from the National Cancer Institute (Frederick, MD) and used to produce ascites. Animals were housed under standard conditions at the University of Cincinnati animal facility.

Immunization and infection of mice with Hc yeast

G217B Hc yeast cells were prepared and quantified as previously described (13). Mice were lightly anesthetized with methoxyfluorane (Mallinckrodt Veterinary, Mundelien, IL), and the yeast suspension was delivered i.n.; 1 x 104 Hc yeast cells were given as a primary inoculum. Mice were allowed to recover for 8 wk. Secondary infection was initiated by inoculation of 2.5 x 106 yeast cells i.n.

RNA extraction

Groups of mice (n = 6) at different stages of Hc infection were sacrificed, and their lungs were flushed of circulating cells by injection of 20 ml HBSS into the right ventricle in situ. Lungs were recovered and homogenized in 4 ml of RNAzol (Biotecx Laboratories, Houston, TX). RNA was extracted with chloroform and precipitated following the manufacturer’s protocol. RNA was resuspended in nuclease-free water, and the nucleic acid yield and purity were determined by OD260 and OD260/OD280 ratio. Samples were kept at -70°C until being processed.

Quantitative reverse-transcribed PCR of V{beta} families

The methodology used to quantify the relative abundance of each V{beta} transcript in lung RNA has been described (14). Briefly, 6 µg of total RNA were annealed with 50 ng of an antisense primer complementary to the constant region of the {beta}-chain (C{beta}1) of TCR. First-strand cDNA synthesis was performed with avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI) and dNTPs. Aliquots of 1 µl of the reverse transcription reaction were used as template in 20 parallel PCR. Each tube contained a common nested antisense primer specific to the constant region of the {beta}-chain (C{beta}2) and each of 20 V{beta}-specific sense primers (14), dNTPs, and Taq polymerase (Promega). Reactions were denatured at 94°C for 45 s, annealed at 59°C for 45 s, and extended at 72°C for 60 s. The number of cycles necessary to produce a visible signal without saturation was determined in preliminary experiments. Between 28 and 32 cycles were used for most samples. The primer sequences have been published (11).

The abundance of each V{beta}-specific PCR product was determined by Southern blot: 5 µl of each PCR were electrophoresed in 1% agarose gels, blotted onto nylon membranes (Roche Biochemicals, Indianapolis, IN), and hybridized with a digoxigenin-labeled DNA probe specific to the C{beta} region of the TCR. After high-stringency washing, 0.1% SSC and 65°C, the signal was revealed with alkaline phosphatase-conjugated anti-digoxigenin Fab (GENIUS system; Boehringer Mannheim, Indianapolis, IN) and the chemiluminescence substrate Lumiphos (Boehringer Mannheim). The light production was measured directly with a ChemiImager 4000 instrument (Alpha Innotech, San Leandro, CA). The relative density index (Rdi) of each band was calculated using the AlphaEase software (Alpha Innotech) according to the formula:

Preparation of mAb

The hybridoma cell lines KT4 (rat anti-mouse V{beta}4 chain of TCR IgG2b) and TR3-10 (anti-mouse V{beta}7 chain of TCR IgG2b) were kindly provided by Dr. Garrison Fathman (Stanford University, Stanford, CA). The hybridoma cell line RR4-7 (rat anti-mouse V{beta}6 chain rat IgG2b) was kindly provided by Dr. Osami Kanagawa (Washington University, St. Louis, MO). Ascites was prepared in nude mice. The IgG fraction was purified using a protein G-agarose column (Pharmacia, Piscataway, NJ), and the concentration of mAb was determined by ELISA using rat IgG as standard.

Depletion of V{beta}+ T cells in vivo

Groups of mice were depleted of V{beta}6+, V{beta}4+, or V{beta}7+ T cells by i.p. injection of 150 µg of mAb, produced from each of the respective hybridomas, on days -7, -3, and the day of infection. Subsequently, mice were injected twice a week until the end of each experiment. Control mice were given an equal amount of rat IgG i.p. The depleting activity of KT4 mAb and TR3-10 mAb has been reported (11).

Isolation of lung leukocytes

Lungs were excised after flushing circulating leukocytes by injecting 10–20 ml of HBSS into the right ventricle. Lungs were minced apart in 10 ml of RPMI 1640, and a single-cell suspension was obtained by forcing the lung fragments through needles of progressively smaller gauge, followed by filtration through a 60-µm nylon mesh. Leukocytes were purified by a 600 x g centrifugation through a discontinuous 40%/70% Percoll gradient and enumerated with a hemacytometer.

Flow cytometry analysis

Determination of the CD4+ or CD8+ phenotypes of V{beta}4+ and V{beta}6+ T cells was performed as follows. Lung leukocytes from infected and control mice were recovered. Cells were resuspended in PBS containing 3% BSA and 0.02% sodium azide. Aliquots of >104 cells were incubated with saturating concentrations of biotin-labeled anti-CD3, anti-V{beta}6, or anti-V{beta}4 (BD PharMingen, San Diego, CA) for 30 min at 4°C. After extensive washing, cells were incubated with FITC-CD4 and PE-CD8 (BD PharMingen). Finally, streptavidin-allophycocyanin (APC) was added. The samples were washed three times, then fixed in 2% paraformaldehyde until flow cytometry analysis was performed. We gated on the APC+ cells (either CD3, V{beta}4, or V{beta}6) and measured the relative proportion of CD4+ cells in the FITC channel and CD8+ cells in the PE channel. The results were calculated by dividing the numbers of double-positive cells by the total number of leukocytes counted by the instrument. Isotype-matched controls were run with each sample to determine the color compensation and the position of the gates.

To determine the percentage of V{beta}4+ and V{beta}6+ T cells with memory phenotype, lung leukocytes from infected immune mice and uninfected controls were incubated with saturating concentrations of anti-CD45 FITC and anti-CD44 PE-labeled mAb (BD PharMingen). After washing, cells were incubated with a second layer of biotin-labeled anti-V{beta}6 or anti-V{beta}4 followed with streptavidin-APC. Flow cytometry enumeration was performed by gating on the V{beta}4+ or V{beta}6+ populations, using the APC channel, and counting the cells with the phenotype CD44highCD45dim (memory). The results were calculated by then dividing the numbers of T cells with memory/effector phenotype by the total number of V{beta}4+ or V{beta}6+ cells detected, respectively.

TCR repertoire in mice depleted of V{beta}6+ T cells

Groups of immune mice were depleted of V{beta}6+ T cells by injection of 150 µg mAb to V{beta}6 as described above. Animals were infected i.n. with 2.5 x 106 Hc yeast cells and sacrificed after 10 and 14 days of infection. A group of V{beta}6+-depleted animals was sacrificed before infection and used as controls (day 0). The lungs were recovered, RNA was extracted, and the V{beta} TCR repertoire was determined by RT-PCR as described above.

Analysis of CDR3 sequences

The PCR products amplified with V{beta}4- and V{beta}6-specific primers were reamplified using a nested common antisense primer complementary to the constant region of the {beta}-chain (C{beta}3). The DNA was purified in agarose gels and ligated in the Topo PCR2.1 cloning vector (Invitrogen, La Jolla, CA). At least 10 random colonies were picked for each mouse and submitted for automated sequencing at the University of Cincinnati DNA core facility. The DNA sequence analysis was performed using a general purpose spreadsheet package (Quattro-Pro 8; Corel, La Jolla, CA) along with a set of purpose-designed functions for recognition and translation of the V{beta}, J{beta}, and CDR3 sequences.

Quantitative organ cultures

Groups of immune mice (n = 10) were injected with anti-V{beta}6, anti-V{beta}4, anti-V{beta}6 plus anti-V{beta}4, or anti-V{beta}6 plus anti-V{beta}7 in different experiments. Control mice were injected with rat IgG. After 7, 14, and 21 days of inoculation with Hc, mice were sacrificed, and lungs and spleens were recovered. The burden of Hc was assessed by quantitative cultures as described previously (13).

Statistics

Analysis was performed with the SigmaStat software (Jandel Scientific, San Rafael, CA). Student’s t test was used to compare the means between two groups. To determine the statistical differences in fungal burden between depleted and control animals, a one-way ANOVA was performed. The Tukey test was applied to perform multiple comparisons among different treatment groups.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Course of secondary infection with Hc

Groups of mice were inoculated i.n. with 104 Hc yeast cells or HBSS and then challenged with 2.5 x 106 yeast cells 8 wk later. The fungal burden was determined at 7, 14 and 21 days of infection. Prior exposure to Hc accelerated the clearance of yeasts at each time point that was assayed (Fig. 1Go).



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 1. Effect of immunization on fungal clearance after a sublethal inoculum with Hc. Groups (n = 6) of C57BL/6 mice were immunized by inoculation of 104 Hc yeast cells i.n. in 50 µl of HBSS or vehicle alone as control. Animals were allowed to clear the primary infection for 8 wk and then challenged with 2.5 x 106 yeast cells. After 7, 14, and 21 days of infection the animals were sacrificed, the lungs and spleens were homogenized in 10 ml of HBSS, and dilutions of the homogenate were plated in solid media. The results are expressed as CFU per organ. Each bar represents the mean ± SE of six individual animals. *, p < 0.01. Prior exposure to Hc results in an increased rate of fungal clearance. One of two experiments is shown.

 
The V{beta}6+ family is expanded during secondary infection with Hc

We examined the dynamic changes in the TCR V{beta} repertoire in the lungs of mice during the course of secondary infection with Hc. The relative abundance of each V{beta} TCR message was determined by semiquantitative RT- PCR and Southern blots, and expressed as Rdi for each V{beta} family, at different days of infection. The results are illustrated in Fig. 2Go. Within each V{beta} family, the Rdi of controls was compared with that of mice infected for 3, 7, 10, 14, and 21 days using a Student’s t test. This analysis was employed because it is sensitive not only to the magnitude of the difference between control and infected animals but also to the consistency of the trend among the individual mice. As five multiple comparisons were made, we applied a Bonferroni correction, setting a p value < 0.01 as significant. The only V{beta} family that was significantly increased was V{beta}6. The Rdi values significantly exceeded those of controls on days 7, 10, and 14 of infection. The remainder of the families did not differ significantly from animals at day 0 of infection by our statistical criteria.



View larger version (61K):
[in this window]
[in a new window]
 
FIGURE 2. V{beta} usage during secondary Hc infection. Groups of mice were immunized and infected with 2.5 x 106 Hc yeast cells i.n. After 3, 7, 10, 14, or 21 days of infection mice were sacrificed and total RNA was extracted from their lungs. A group of uninfected animals was used as control (day 0). RNA was reverse transcribed, and each V{beta} family was amplified by PCR and visualized by Southern blot. For every mouse, the Rdi was computed. Each bar represents the mean ± SEM of six mice. The mean Rdi at every time point was compared with the respective mean Rdi in the control group. *, p < 0.01.

 
Analysis of the CDR3 repertoire of V{beta} subfamilies

We reamplified and cloned the V{beta}6 PCR products from lungs of mice at days 0, 3, 7, 10, 14, and 21 of infection; three to five mice per group were analyzed. Results are summarized in Table IGo. At day 0, the CDR3 sequences were diverse. Mice A and C manifested a single sequence found in two independent clones, encompassing two of 10 sequences. At day 3, mice D and E showed an equally diverse pattern in sequences, but the ones from mouse F were clustered into two groups. Four of six sequences contained the CDR3 sequence RGL followed by the J{beta}2.4 element, and two of six possessed the IAGA sequence followed by the J{beta}1.1 element. At day 7, the CDR3 sequences from mice G and I displayed oligoclonality; 50% of the sequences from these mice belonged to a dominant motif characterized by IPP-J{beta}2.3 and IARG-J{beta}2.3, respectively. Sequences from mouse H were heterogeneous, but contained several motifs in common with other mice. At days 10, 14, and 21, the CDR3 sequences were polyclonal, with the exception of mouse Q at day 21, in which five of seven independent sequences were identical.


View this table:
[in this window]
[in a new window]
 
Table I. Summary of V{beta}6 CDR3 sequences1

 
Among all mice at each stage of infection, the motif IAGA followed by the J{beta}1.1 element was observed in 10 of 115 (8.7%) CDR3 sequences, and the motif IARG-J{beta}2.3 was identified in 4 of 115 (3.5%) sequences. None of these profiles were detected in the controls.

Because V{beta}4+ cells were prominent in primary infection and displayed oligoclonality on days 7–14 postinfection, we analyzed the CDR3 sequences of this population to determine whether there was a skewing. Sequences from days 0, 3, 7, 10, 14, and 21 are depicted in Table IIGo. The CDR3 sequences of mice A and B on day 0 were diverse; all the sequences were either distinct or present in no more than two independent clones. The sequences from mouse C were clustered around two motifs. Four of 10 sequences contained DPGQ followed by the J{beta}1.4 element, and 3 of 10 exhibited the motif DGGQG associated with the J{beta}1.2 element. At day 3, the CDR3 differed in all mice except mouse E in which the sequence EWD linked to J{beta}2.6 was evident in three of 10 clones. Mouse F sequences were diverse, but some of their VDJ amino acid motifs were found in other infected mice. CDR3 sequences from mice infected for 7 days revealed that 5 of 10 sequences from mouse H were identical, as well as four of seven from mouse I and six of seven from mouse J. Sequences at days 10 and 14 postinfection were highly diverse. Only mouse O contained 6 of 10 sequences that were identical: the sequence NG connected to the J{beta}2.6 element. At day 21, the sequences tended to be diverse, with the exception of mouse R, in which six of 10 sequences contained the motif DAR followed by the J{beta}1.1 element.


View this table:
[in this window]
[in a new window]
 
Table II. Summary of V{beta}4 CDR sequences1

 
Several CDR3 motifs were present in more than one mouse: DAR followed by the J{beta}1.1 element was found in one of the sequences from mouse F at day 3 of infection and in six of the sequences from mouse R at day 21 of infection. DGGQG followed by the J{beta}2.6 element was shared between mouse C in the control group and mouse J. The sequence GPDSSG followed by the J{beta}1.3 element was found in mice F and I, as well as the sequence PGNG followed by J{beta}2.5.

J{beta} usage in the V{beta} repertoire

During primary infection we observed that the J{beta}2.1 element was highly prevalent (19–24% of V{beta}4 sequences) in mice infected for 7–14 days, but was not found in naive mice. In reexposure histoplasmosis, the J{beta}2.1 element is present in 11% of the sequences at baseline and does not change significantly during the course of infection (Table IIIGo). In contrast, the J{beta}2.4 element was present in 6% of the sequences from uninfected mice or mice at day 3 of infection, but on day 7 of infection, 28% of the V{beta}4 chains were combined with the J{beta}2.4 element, and 18% at day 10. At day 14 the J{beta}2.4 usage was 8%.


View this table:
[in this window]
[in a new window]
 
Table III. J{beta} usage among V{beta}4 sequences1

 
CD4+ and CD8+ expression among V{beta}6+ and V{beta}4+ T cells from lungs of mice with reinfection Hc

We sought to determine the distribution of CD4+ and CD8+ among V{beta}6+ and V{beta}4+ T cells infiltrating the lungs of infected mice. As a reference, we determined the relative proportion of CD4+ and CD8+ cells among all, CD3+, T cells. At day 0, CD3+ comprised 10.9% of the leukocytes in the lungs, and 54.9% of them were CD4+. The proportion of lung leukocytes that were CD3+ peaked on day 7 to 44.2% and subsequently declined (Fig. 3GoA). Analysis of the V{beta}6+ cells (Fig. 3GoB) showed that this subpopulation encompassed 0.9% of lung leukocytes before the onset of infection and became 4.2% of lung leukocytes by day 10, the peak of their expansion. At this day, 96.7% of V{beta}6+ cells were CD4+. V{beta}4+ cells underwent a more modest expansion (Fig. 3GoC). At its peak, day 7, 2.2% of lung leukocytes were V{beta}4+, and 93.6% of them were CD4+.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 3. CD4+ and CD8+ expression on CD3+ (A), V{beta}6+(B), or V{beta}4+ (C) cells from lungs of mice reexposed to Hc i.n. Mice (n = 6) were sacrificed after different intervals postinfection, and leukocytes were extracted from their lungs and stained with biotin-labeled mAb to either anti-CD3+, -V{beta}6+, or -V{beta}4+ followed by streptavidin-APC. A second layer with anti-CD4-FITC and CD8-PE was added, and the cells were enumerated in a flow cytometer as follows. After selecting the lymphocyte population by forward and side scatter, we gated in the APC+ cells that expressed CD3+, V{beta}6+, or V{beta}4+, respectively. Within each of the gated populations the CD4+ and the CD8+ cells were quantified by two-color analysis. The results are calculated as the fraction of total lung leukocytes that were CD3+CD4+ or CD3+CD8+ (A), V{beta}6+CD4+ or V{beta}6+CD8+ (B), or V{beta}4+CD4+ or V{beta}4+CD8+ (C) at different days of infection. Each bar represents the mean ± SEM.

 
Effect of primary infection on the V{beta}6+ and V{beta}4+ T cells with memory phenotype

We asked whether the expansion of V{beta}6+ T cells observed during secondary infection was preceded by an enrichment of cells with memory phenotype before the secondary challenge with Hc. The results are shown in Fig. 4Go. At day 0, 8 wk after primary infection but before reexposure, 12.5% of V{beta}6+ cells had CD44highCD45dim phenotype, in contrast to 4% in naive animals. Among V{beta}4+ T cells, the frequency of memory phenotype in naive animals was 4% as compared with 6% in mice previously exposed to Hc. After secondary challenge with Hc, we observed an influx of T cells with memory phenotype that followed a similar pattern between V{beta}4+ and V{beta}6+ families. At day 3 of infection, the frequency of CD44highCD45dim phenotype peaked to 22% for V{beta}4+ and 18% for V{beta}6+ and declined in both families thereafter.



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 4. Memory phenotype among V{beta}4+ or V{beta}6+ T cells during secondary infection. Immune mice (n = 6) were sacrificed at different stages after Hc reexposure. A group of naive animals was sacrificed and used as reference. Leukocytes were isolated from their lungs and stained with anti-CD45-FITC, anti-CD44-PE, or biotin-labeled anti-V{beta}4+ or anti-V{beta}6+ followed by streptavidin-APC. Flow cytometry analysis was performed by gating on V{beta}4+ or V{beta}6+ cells and counting the cells with CD44highCD45dim (memory/effector) phenotype. The number was divided by the total V{beta}4+- or V{beta}6+-detected cells and expressed as a percentage. Each bar represents the mean ± SEM. Significant differences are denoted by the p value in the graph.

 
Effect of V{beta}6+ and/or V{beta}4+ T cell depletion in the clearance of Hc secondary infection

Amplification of the V{beta}6+ population does not necessarily correlate with functional importance. To address this issue, we selectively depleted this population in vivo by injection of mAb to V{beta}6 and evaluated the course of infection. As a control, separate groups of mice were given rat IgG. In preliminary experiments, we determined whether administration of the RR4-7 mAb was effective in depleting V{beta}6+ T cells. We harvested leukocytes from lungs of treated or control mice (n = 6/group) after 7 days of infection and analyzed the frequency of V{beta}6+ T cells by flow cytometry. V{beta}6+ constituted 12.6 ± 2.8% of lung leukocytes in infected nondepleted mice and 0.8 ± 0.2% in depleted mice. Thus, the mAb treatment produced a 94% reduction in the frequency of V{beta}6+ T cells.

Subsequently, we sacrificed depleted or control animals at 7, 14, and 21 days postinfection. We homogenized lungs and spleens and determined the burden of Hc CFU in each organ. Depletion of V{beta}6+ cells produced a significant 0.6 log10 increase in fungal burden in the lungs of infected mice at day 7 of infection (Fig. 5GoA). Organ cultures at day 21 showed an almost complete clearance of infection in all groups and were excluded from all further analyses.



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 5. Clearance of secondary histoplasmosis in mice depleted of V{beta} families. Groups of mice were administered either rat IgG (controls), mAb to V{beta}6 alone, or V{beta}4 alone in A. Other groups of mice were given either rat IgG, mAb to V{beta}6 alone, V{beta}6 + V{beta}7, or V{beta}6 + V{beta}4, depicted in B. Doses of 150 µg of mAb or rat IgG i.p. were given on days -7, -3, and 0 of infection and twice a week thereafter. Infection was initiated at day 0 with 2.5 x 106 yeast cells i.n. At 7 and 14 days of infection, animals were sacrificed, and organs were homogenized in 10 ml of HBSS. Serial dilutions were plated in blood agar plates, and Hc CFU was quantified. Results are expressed as log10 CFU/organ. Each represents the mean ± SEM of at least six mice. Pooled results from two experiments are depicted. *, p < 0.03; ¶, p < 0.01; and {ddagger}, p < 0.05.

 
We simultaneously tested whether elimination of V{beta}4+ T cells could have an impact on fungal clearance during secondary infection because this subpopulation was necessary for optimal clearance during primary infection (11). Mice depleted of V{beta}4+ T cells cleared secondary infection as efficiently as rat IgG-treated infected controls (Fig. 5GoA).

We then examined whether dual depletion of V{beta}6+ and V{beta}4+ produced a greater alteration in host resistance than depletion of V{beta}6+ cells alone. As a control, groups of mice were administered mAb to V{beta}6 and V{beta}7 concomitantly. CFU from lungs and spleens of mice given both mAb to V{beta}6 and V{beta}7 did not differ significantly (p > 0.05) from those given mAb to V{beta}6 alone, although both groups contained higher CFU than the lungs of nondepleted control animals at day 7 of infection (Fig. 5GoB). In contrast, simultaneous depletion of V{beta}6+ and V{beta}4+ T cells unequivocally impaired the ability to clear Hc from either lungs or spleens at days 7 and 14 postinfection.

Effect of V{beta}6+ depletion on the V{beta} TCR repertoire

We sought to determine whether the depletion of a discrete V{beta} family would induce a compensatory expansion of other V{beta} subset(s). We chose to analyze the repertoire at days 10 and 14 of infection because all significant V{beta} expansions that we have observed during primary and secondary infection have occurred during these phases of peak of infection and early clearance. The repertoire of depleted and control animals was not significantly different at days 10 and 14 of infection, except for the almost complete abrogation of the V{beta}6 signal (data not shown).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We used a model of pulmonary histoplasmosis to characterize the V{beta} TCR repertoire during a secondary challenge with the pathogen. We concentrated on the lungs for two reasons. First, the lung is the natural portal of entry of natural Hc infection. Second, lung tissues are useful for studying the dynamic changes of T cell subpopulations. Uninfected lungs harbor only a small number of resident T cells. After an infectious challenge, there is a massive influx of inflammatory cells, including T lymphocytes, into this organ (10).

When we examined the V{beta} TCR repertoire in immune animals infected with Hc, several differences became apparent. Secondary infection with Hc produced a bias toward a discrete T cell family, V{beta}6+. The dynamics of this expansion were analogous to those of the V{beta}4+ family during the primary infection. The V{beta}6+ family was not significantly expanded at day 3 of infection, became dominant at days 7, 10, and 14, and returned toward baseline at day 21 of infection. The bias of the V{beta} repertoire occurred between days 7 and 14 of infection in a fashion that mirrored the influx of cells of lymphoid phenotype into the infected lungs.

When we sequenced across the CDR3 of V{beta}4+ cells from primary infection, V{beta}6+ from secondary infection, as well as V{beta}4+ cells from secondary infection, we detected a recurrent pattern. Before inoculation (day 0) and during the early phase (day 3) of infection, the CDR3 sequences tended to be diverse. During the peak and early resolution phases (days 7–10) of infection, the sequences converged toward a small number of dominant motifs. Finally, at the later stages of infection (days 14 and 21), the CDR3 sequences became diverse again. The finding of oligoclonality is suggestive of an Ag-driven process. The diversity of sequences at the later stages of infection can be attributed to a nonspecific influx of inflammatory cells, as has been demonstrated in a model of autoimmune insulitis (15).

The preferential expansion of a particular V{beta} family might be ascribed to any of three circumstances: 1) the presence of a superantigen, 2) the accretion of independent TCR clonotypes, each directed toward a different antigenic determinant but all sharing the same V{beta}-chain of the TCR, or 3) the presence of dominant antigenic determinants that stimulate the expansion of T cell clonotypes with a limited number of V{beta}-chains and CDR3. Oligoclonality in the CDR3 sequences, along with several instances of CDR3 sequences found independently in more than one mouse, strongly argue for the third possibility. Reiner et al. (16) described a strong bias toward the V{beta}4 family in the TCR repertoire of mice infected with Leishmania major. V{beta}4+ T cells derived from these mice were eventually demonstrated to recognize the immunodominant Leishmania homologue of receptors for activated C kinase Ag from L. major (17). Our results suggest that a dominant Ag or Ags from Hc are the driving stimulus for the bias and oligoclonality in the V{beta} repertoire in this model of infection. Work is in progress to identify the antigenic targets of V{beta}4+ T cells recovered from the lungs of mice with primary infection and of V{beta}6+ T cells from mice with reinfection histoplasmosis.

None of the V{beta} families that were significantly expanded during primary infection displayed an increase upon reexposure to Hc. V{beta}6, the only family that exhibited significant amplification during secondary infection, was not significantly expanded in the lungs of naive mice infected with Hc. One explanation for these findings is that the Ag(s) recognized by V{beta}6+ cells were cryptic in primary infection. Conversely, it is possible that both primary and secondary responses were directed against the same dominant Hc Ag(s), but T cells specific for this Ag use the V{beta}4 chain preferentially in primary infection and the V{beta}6 element in secondary histoplasmosis. The report by Busch et al. (18) illustrates these possibilities. In a murine model of listerosis, the TCR repertoire was biased to the same V{beta} families in both primary and secondary infection in all but one mouse. The lone exception displayed a shift in the dominant family from V{beta}8+ during primary infection to V{beta}2+ during recall immune response.

A more subtle finding emerged when we retrospectively compared the TCR repertoire of naive and immune mice before the infectious challenge. The relative abundance of most V{beta} subpopulations is not significantly different between the groups. Also, the repertoire at day 21, corresponding to the late clearance phase of the infection, is not significantly different from the repertoire at day 0. This comparison has a caveat. The data came from two independent, nonsimultaneous experiments instead of two groups run in parallel. However, this result does suggest that the process of primary infection with Hc did not produce a measurable, permanent alteration of the baseline repertoire. Only during active infection, days 7–14, were we able to detect significant deviations within the V{beta} repertoire.

Additional phenotypic analysis of V{beta}6+ and V{beta}4+ cells revealed several interesting features. A large majority of each V{beta} family coexpressed the CD4 receptor. This finding was in line with the observation that among CD3+ cells from the lungs, CD4+ cells comprised the highest proportion. In addition, we observed that the expansion of V{beta}6+ cells was preceded by an increased proportion of the memory cells within this subset. In contrast, the expansion of V{beta}4+ T cells during primary infection did not result in a residual enrichment of memory V{beta}4+ T cells in the lungs before reexposure to Hc. Nevertheless, after the onset of secondary infection, the flux of memory cells was similar in both V{beta}6+ and V{beta}4+ cells.

Depletion of CD4+ but not CD8+ T cells impairs fungal clearance in reexposure histoplasmosis, in contrast with a substantial increase in mortality during primary infection (9). Simultaneous elimination of CD4+ and CD8+ T cells completely abrogates protective immunity in secondary infection with Hc. In our studies, we asked whether V{beta}6+ T cells were necessary for optimal clearance of Hc infection in immune mice. Deletion of this family produced a modest but significant effect on Hc clearance detectable only on day 7 of infection, whereas animals depleted of V{beta}4+ T cells eliminated Hc as efficiently as infected controls. Despite the loss of the amplified V{beta}6+ population, the impact on host resistance was not striking, suggesting that host defenses developed compensatory mechanisms to combat infection. Because V{beta}4+ cells exhibited a prominent influence on the course of primary infection, we tested the possibility that simultaneous elimination of V{beta}4+ and V{beta}6+ cells caused a more dramatic effect on host resistance. Indeed, the absence of both families resulted in an unequivocal and pronounced impairment of host defenses against Hc that was greater than that observed with elimination of either family. This effect was specific for the loss of both V{beta}6+ and V{beta}4+ cells because elimination of the former and V{beta}7+ cells did not impair host defenses more than depletion of V{beta}6+ cells alone. Thus, V{beta}6+ and V{beta}4+ manifest a cooperative interaction in resistance to Hc.

In conclusion, immunization with viable Hc modifies the lung V{beta} TCR repertoire. During days 7, 10, and 14 of infection, V{beta}6+ cells are significantly expanded in the lungs of immune C57BL/6 mice, which is in contrast to the finding that V{beta}4+ T cells are amplified in primary infection. Immune mice display an increased frequency of V{beta}6+ T cells with memory phenotype before the onset of secondary infection. The CDR3 sequences of V{beta}4 and V{beta}6 chains converge toward oligoclonality during days 7–10 of secondary infection. Selective deletion of V{beta}6+ cells hinders optimal clearance of the fungus in secondary histoplasmosis. Moreover, depletion of both V{beta}6+ and V{beta}4+ T cells, which represent the predominant T cell families expanded during secondary and primary Hc infection, respectively, induced a more profound and sustained defect in the course of fungal clearance.


    Footnotes
 
1 This work was supported by U.S. Public Health Service Grants AI-42747 and AI-34361. F.J.G. was recipient of a Veterans Administration Career Development Award. Back

2 Address correspondence and reprint requests to Dr. George S. Deepe, Jr., Infectious Diseases Division, University of Cincinnati College of Medicine, 231 Bethesda Avenue, ML 560, Cincinnati, OH 45267-0560. Back

3 Abbreviations used in this paper: Hc, Histoplasma capsulatum; i.n., intranasal; Rdi, relative density index; CDR, complementarity determinant region; APC, allophycocyanin. Back

Received for publication April 13, 2000. Accepted for publication November 27, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Williams, D. M., J. R. Graybill, D. J. Drutz. 1978. Histoplasma capsulatum infection in nude mice. Infect. Immun. 21:973.[Abstract/Free Full Text]
  2. Bullock, W. E.. 1993. Interactions between human phagocytic cells and Histoplasma capsulatum. Arch. Med. Res. 24:219.[Medline]
  3. Jr Goodwin, R. A., R. M. Des Prez. 1973. Pathogenesis and clinical spectrum of histoplasmosis. South. Med. J. 66:13.[Medline]
  4. Allendoerfer, R., D. M. Magee, Jr G. S. Deepe, J. R. Graybill. 1993. Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect. Immun. 61:714.[Abstract/Free Full Text]
  5. Jr Deepe, G. S.. 1994. The immune response to Histoplasma capsulatum: unearthing its secrets. J. Lab. Clin. Med. 123:201.[Medline]
  6. Jr Deepe, G. S.. 1993. Histoplasma capsulatum and V{beta}a mice: cellular immune responses and susceptibility patterns. J. Med. Vet. Mycol. 31:181.[Medline]
  7. Jr Deepe, G. S.. 1994. Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152:3491.[Abstract]
  8. Gomez, A. M., W. E. Bullock, C. L. Taylor, Jr G. S. Deepe. 1988. Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect. Immun. 56:1685.[Abstract/Free Full Text]
  9. Allendoerfer, R., G. D. Brunner, Jr G. S. Deepe. 1999. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J. Immunol. 162:7389.[Abstract/Free Full Text]
  10. Cain, J. A., Jr G. S. Deepe. 1998. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 66:1473.[Abstract/Free Full Text]
  11. Gomez, F. J., J. A. Cain, R. Gibbons, R. Allendoerfer, Jr G. S. Deepe. 1998. V{beta}4+ T cells promote clearance of infection in murine pulmonary histoplasmosis. J. Clin. Invest. 102:984.[Medline]
  12. Allendoerfer, R., Jr G. S. Deepe. 1998. Blockade of endogenous TNF-{alpha} exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 160:6072.[Abstract/Free Full Text]
  13. Gomez, F. J., A. M. Gomez, Jr G. S. Deepe. 1991. Protective efficacy of a 62-kDa antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect. Immun. 59:4459.[Abstract/Free Full Text]
  14. Casanova, J. L., P. Romero, C. Widmann, P. Kourilsky, J. L. Maryanski. 1991. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. 174:1371.[Abstract/Free Full Text]
  15. Yang, Y., B. Charlton, A. Schemata, R. Dal Canto, C. G. Fathman. 1996. Monoclonal T cells identified in early NOD islet infiltrates. Immunity 4:189.[Medline]
  16. Reiner, S. L., Z. E. Wang, F. Hatam, P. Scott, R. M. Locksley. 1993. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science 259:1457.[Abstract/Free Full Text]
  17. Carat, N., E. Pina, E. Maghniyya, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762.[Medline]
  18. Busch, D. H., I. Pilip, E. G. Pamer. 1998. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J. Exp. Med. 188:61.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
A. I. Medeiros, A. Sa-Nunes, W. M. Turato, A. Secatto, F. G. Frantz, C. A. Sorgi, C. H. Serezani, G. S. Deepe Jr., and L. H. Faccioli
Leukotrienes Are Potent Adjuvant during Fungal Infection: Effects on Memory T Cells
J. Immunol., December 15, 2008; 181(12): 8544 - 8551.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Wuthrich, H. I. Filutowicz, H. L. Allen, G. S. Deepe, and B. S. Klein
V{beta}1+ J{beta}1.1+/V{alpha}2+ J{alpha}49+ CD4+ T Cells Mediate Resistance against Infection with Blastomyces dermatitidis
Infect. Immun., January 1, 2007; 75(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Heninger, L. H. Hogan, J. Karman, S. Macvilay, B. Hill, J. P. Woods, and M. Sandor
Characterization of the Histoplasma capsulatum-Induced Granuloma.
J. Immunol., September 1, 2006; 177(5): 3303 - 3313.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. M. Lindell, M. N. Ballinger, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Diversity of the T-Cell Response to Pulmonary Cryptococcus neoformans Infection.
Infect. Immun., August 1, 2006; 74(8): 4538 - 4548.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J.-S. Lin and B. A. Wu-Hsieh
Functional T cells in primary immune response to histoplasmosis
Int. Immunol., November 1, 2004; 16(11): 1663 - 1673.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. R. Johnson, S. M. Varga, T. J. Braciale, and B. S. Graham
V{beta}14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV
J. Virol., August 15, 2004; 78(16): 8753 - 8760.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Scheckelhoff and G. S. Deepe Jr.
The Protective Immune Response to Heat Shock Protein 60 of Histoplasma capsulatum Is Mediated by a Subset of V{beta}8.1/8.2+ T Cells
J. Immunol., November 15, 2002; 169(10): 5818 - 5826.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. S. Deepe Jr., R. S. Gibbons, and S. R. Ward
Discordance between T-Cell Receptor Expression and Effector Function in Mice Infected with Histoplasma capsulatum
Infect. Immun., March 1, 2002; 70(3): 1648 - 1652.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Deepe Jr. and R. Gibbons
V{beta}6+ T Cells Are Obligatory for Vaccine-Induced Immunity to Histoplasma capsulatum
J. Immunol., August 15, 2001; 167(4): 2219 - 2226.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez, F. J.
Right arrow Articles by Deepe, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez, F. J.
Right arrow Articles by Deepe, G. S., Jr.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS